Citations

Mayo Clinic

Showing 10 of 108537 citations.

Cardiovascular Safety and Romosozumab—The Plot Thickens
Farr, Joshua N. , Farr, Joshua N

The Journal of Clinical Endocrinology & Metabolism | May 8, 2024 | Volume: 110 | Issue: 1 | Pages: e190-e191

10.1210/clinem/dgae313 | PMID 38717942 Get It

Cardiac biomarkers for diagnosing Takotsubo syndrome
Schweiger, Victor , Vece, Davide Di , Cammann, Victoria L. , Koleva, Iva, Würdinger, Michael , Gilhofer, Thomas , Rajman, Katja, Szawan, Konrad A. , Niederseer, David , Gili, Sebastiano , Franke, Jennifer , Meder, Benjamin , Knorr, Maike, Jansen, Thomas , Bruno, Francesco , Filippo, Ovidio De , Stefanini, Giulio , Wańha, Wojciech , Lewinski, Dirk von , Burgdorf, Christof , Kherad, Behrouz , Tschöpe, Carsten , Sarcon, Annahita, Shinbane, Jerold S., Rajan, Lawrence, Michels, Guido, Pfister, Roman , Jacobshagen, Claudius, Karakas, Mahir , Pott, Alexander , Meyer, Philippe , Roffi, Marco , Wolfrum, Mathias , Fischer, Thomas, Vasankari, Tuija , Dworakowski, Rafał , MacCarthy, Philip , Osswald, Stefan , Galiuto, Leonarda , Chan, Christina , Bridgman, Paul , Beug, Daniel , Gilyarova, Ekaterina, Poledníková, Karolína, Massoomi, Michael , Carrilho‐Ferreira, Pedro , Hauck, Christian , Paolini, Carla , Bilato, Claudio , Kobayashi, Yoshio , Ishibashi, Iwao, Himi, Toshiharu, Din, Jehangir , Rihal, Charanjit S. , Jörg, Lucas, Rickli, Hans , Böhm, Michael , Pinto, Fausto J. , Widimský, Petr , Felix, Stephan B. , Rottbauer, Wolfgang , Budnik, Monika , Opolski, Grzegorz , Kong, William , Dalakoti, Mayank , Imori, Yoichi , Münzel, Thomas , Lüscher, Thomas F. , Ghadri, Jelena R. , Templin, Christian , Citro, Rodolfo , Vecchione, Carmine , Bossone, Eduardo , Meder, Benjamin , Bruno, Francesco , De Filippo, Ovidio , Campo, Gianluca , von Lewinski, Dirk , Tschöpe, Carsten , Pfister, Roman , Koenig, Wolfgang , Meyer, Philippe , Banning, Adrian , Kobza, Richard , Galiuto, Leonarda , Lairez, Olivier , Gilyarov, Mikhail , Akin, Ibrahim , Ukena, Christian , Hauck, Christian , Paolini, Carla , Bilato, Claudio , Böhm, Michael , Widimský, Petr , Rottbauer, Wolfgang , Schunkert, Heribert , Thiele, Holger , Bauersachs, Johann , Di Mario, Carlo , Bax, Jeroen J , Templin, Christian , Koleva, Iva, Citro, Rodolfo , Vecchione, Carmine , Bossone, Eduardo , Neuhaus, Michael, Jaguszewski, Miłosz , Noutsias, Michel , D’Ascenzo, Fabrizio , Campo, Gianluca , Raposeiras‐Roubín, Sergio , Dichtl, Wolfgang , Cuneo, Alessandro , Köenig, Wolfgang , Banning, Adrian , Cuculi, Florim , Kobza, Richard , Airaksinen, Juhani , Napp, L. Christian , Kaiser, Christoph A. , Delmas, Clément , Lairez, Olivier , Shilova, Alexandra S. , El‐Battrawy, Ibrahim , Toušek, Petr , Winchester, David E. , Gałuszka, Jan , Ukena, Christian , Poglajen, Gregor , Kato, Ken , Al‐Shammari, Ali Saad , Prasad, Abhiram , Rihal, Charanjit S. , Liu, Kan , Schulze, Paul Christian , Bianco, Matteo , Pestana, Gonçalo , Nguyen, Thanh Ha Tuan , Maier, Lars S. , Braun-Dullaeus, Ruediger Christian , Hasenfuß, Gerd , Pieske, Burkert , Horowitz, John D. , Mario, Carlo Di , Bax, Jeroen J. , Crea, Filippo , Ruschitzka, Frank T.

European Heart Journal | May 8, 2024 | Volume: 45 | Issue: 25 | Pages: 2254-2258

10.1093/eurheartj/ehae231 | PMID 38717630 Get It

Promoting Growth in Behavioral Neurology: A Path Forward
Josephy‐Hernandez, Sylvia , Apostolova, Liana G. , Budson, Andrew E. , Chemali, Zeina , Lin, Chi‐Ying , Daffner, Kirk R. , Geschwind, Michael D., Heilman, Kenneth M. , Holden, Samantha K. , Jaffee, Michael S., Kletenik, Isaiah , Love, Marissa Natelson , Moo, Lauren R. , Pelak, Victoria S. , Press, Daniel Z. , Ramírez-Gómez, Liliana , Rosen, Howie, Vaishnavi, Sanjeev , Windon, Charles , Hamilton, Roy H. , Perez, David L. , Hamilton, Roy , Windon, Charles , Hamilton, Roy H , Bateman, James R. , Benjamin, Sheldon , Barrett, Anna M. , Boeve, Bradley F. , Hillis, Argye Elizabeth , Schmahmann, Jeremy Dan

Cognitive and Behavioral Neurology | May 8, 2024 | Volume: 37 | Issue: 2 | Pages: 49-56

10.1097/wnn.0000000000000368 | PMID 38717325 Get It

Behavioral neurology & neuropsychiatry (BNNP) is a field that seeks to understand brain–behavior relationships, including fundamental brain organization principles and the many ways that brain structures and connectivity can be disrupted, leading to abnormalities of behavior, cognition, emotion, perception, and social cognition. In North America, BNNP has existed as an integrated subspecialty through the United Council for Neurologic Subspecialties since 2006. Nonetheless, the number of behavioral neurologists across academic medical centers and community settings is not keeping pace with increasing clinical and research demand. In this commentary, we provide a brief history of BNNP followed by an outline of the current challenges and opportunities for BNNP from the behavioral neurologist’s perspective across clinical, research, and educational spheres. We provide a practical guide for promoting BNNP and addressing the shortage of behavioral neurologists to facilitate the continued growth and development of the subspecialty. We also urge a greater commitment to recruit trainees from diverse backgrounds so as to dismantle persistent obstacles that hinder inclusivity in BNNP—efforts that will further enhance the growth and impact of the subspecialty. With rapidly expanding diagnostic and therapeutic approaches across a range of conditions at the intersection of neurology and psychiatry, BNNP is well positioned to attract new trainees and expand its reach across clinical, research, and educational activities.
Carotid artery calcium score: Definition, classification, application, and limits
Saba, Luca , Benson, John C. , Scicolone, Roberta , Paraskevas, Kosmas I. , Gupta, Ajay , Cau, Riccardo , Suri, Jasjit S. , Schindler, Andreas , Balestrieri, Antonella , Nardi, Valentina , Song, Jae W , Wintermark, Max , Benson, John , Paraskevas, Kosmas I , Cau, Riccardo , Nardi, Valentina , Saba, Luca , Suri, Jasjit S. , Song, Jae W. , Wintermark, Max , Lanzino, Giuseppe

The Neuroradiology Journal | May 8, 2024 | Volume: 37 | Issue: 5 | Pages: 611-619

10.1177/19714009241252623 | PMID 38718167 Get It

Introduction In the current paper, the “carotid artery calcium score” method is presented with the target to offer a metric method to quantify the amount of calcification in the carotid artery. Model and Definition The Volume of Interest (VOI) should be extracted and those voxels, with a Hounsfield Unit (HU) value ≥130, should be considered. The total weight value is determined by calculating the sum of the HU attenuation values of all voxels with values ≥130 HU. This value should be multiplied by the conversion factor (“or voxel size”) and divided by a weighting factor, the attenuation threshold to consider a voxel as calcified (and therefore 130 HU): this equation determines the Carotid Artery Calcium Score (CACS). Results In order to provide the demonstration of the potential feasibility of the model, the CACS was calculated in 131 subjects (94 males; mean age 72.7 years) for 235 carotid arteries (in 27 subjects, unilateral plaque was present) considered. The CACS value ranged from 0.67 to 11716. A statistically significant correlation was found (rho value = 0.663, p value = .0001) between the CACS in the right and left carotid plaques. Moreover, a statistically significant correlation between the age and the total CACS was present (rho value = 0.244, p value = .005), whereas no statistically significant difference was found in the distribution of CACS by gender ( p = .148). The CACS was also tested at baseline and after contrast and no statistically significant difference was found. Conclusion In conclusion, this method is of easy application, and it weights at the same time the volume and the degree of calcification in a unique parameter. This method needs to be tested to verify its potential utility, similar to the coronary artery calcium score, for the risk stratification of the occurrence of cerebrovascular events of the anterior circulation. Further studies using this new diagnostic tool to determine the prognostic value of carotid calcium quantification are needed.
Alone: AJR Podcast Series on Wellness, Episode 2
Wang, Sherry S.

American Journal of Roentgenology | May 8, 2024 | Volume: 222 | Issue: 6 | Pages: No page available

10.2214/ajr.24.31377 | PMID 38717244 Get It

Phage K exposure generates phage-neutralizing activity in a rabbit model—humoral receptiveness may impact efficacy of phage therapy
Herren, Sebastian , Karau, Melissa J. , Koscianski, Christina, Christensen, Trace , Granger, Dane, Bergan, Nathanial G., Mandrekar, Jay , Holmes, David R. , Patel, Robin , Parmar, Krupa , Herren, Sebastian C , Koscianski, Christina A, Patel, Robin , Bergan, Natalie, Holmes, David R.

Antimicrobial Agents and Chemotherapy | May 8, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1128/aac.00052-24 | PMID 38717092 Get It

ABSTRACT Phage therapy has not been established in the clinical routine, in part due to uncertainties concerning efficacy and immunogenicity. Here, three rabbits were immunized against staphylococcal phage K to assess viral potency in the presence of immunized serum. Three rabbits received weekly intramuscular injections of ~10 10±1 pfu/mL phage K. Phage K-specific IgG formation was measured by an enzyme-linked immunosorbent assay (ELISA); phage inactivation was assessed by calculating K-rates. Using transmission electron microscopy (TEM) and immunogold labeling, antibody binding to phage K was visualized. This was numerically assessed by objective imaging analysis comparing the relative distances of each gold particle to the nearest phage head and tail structure. Immunization led to a strong IgG response, plateauing 7 days after the last phage injection. There was no significant correlation between K-rate and antibody titer over time. TEM showed IgG binding to the head structure of phage K. Image analysis showed a significant reduction in relative distances between antibodies and phage head structures when comparing samples from day 0 and day 28 ( P < 0.0001). These results suggest that while individual serum analysis for antibodies against therapeutic phage bears consideration prior to and with prolonged therapy, during phage application, the formation of specific antibodies against phage may only partially explain decreased phage potency in the presence of immunized serum. Instead, other factors may contribute to an individual’s “humoral receptiveness” to phage therapy. Future investigations should be directed toward the identification of the humoral factors that have the most significant predictive value on phage potency in vivo .
Chitosan-2D Nanomaterial-Based Scaffolds for Biomedical Applications
Naskar, Atanu , Kilari, Sreenivasulu , Misra, Sanjay , Misra, Sanjay , Naskar, Atanu , Kilari, Sreenivasulu , Misra, Sanjay

Polymers | May 8, 2024 | Volume: 16 | Issue: 10 | Pages: 1327

10.3390/polym16101327 | PMID 38794520 Get It

Chitosan (CS) and two-dimensional nanomaterial (2D nanomaterials)-based scaffolds have received widespread attention in recent times in biomedical applications due to their excellent synergistic potential. CS has garnered much attention as a biomedical scaffold material either alone or in combination with some other material due to its favorable physiochemical properties. The emerging 2D nanomaterials, such as black phosphorus (BP), molybdenum disulfide (MoS2), etc., have taken huge steps towards varying biomedical applications. However, the implementation of a CS-2D nanomaterial-based scaffold for clinical applications remains challenging for different reasons such as toxicity, stability, etc. Here, we reviewed different types of CS scaffold materials and discussed their advantages in biomedical applications. In addition, a different CS nanostructure, instead of a scaffold, has been described. After that, the importance of 2D nanomaterials has been elaborated on in terms of physiochemical properties. In the next section, the biomedical applications of CS with different 2D nanomaterial scaffolds have been highlighted. Finally, we highlighted the existing challenges and future perspectives of using CS-2D nanomaterial scaffolds for biomedical applications. We hope that this review will encourage a more synergistic biomedical application of the CS-2D nanomaterial scaffolds and their utilization clinical applications.
Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance)
Nakasone, Elizabeth S. , Lin, She Yu, Innocenti, Federico , Cohen, Stacey A. , Zemla, Tyler J, Cohen, Stacey A , Zemla, Tyler , Yu, Ming , Ou, Fang‐Shu , Carter, Kelly , Saltz, Leonard B. , Grady, William M.

Epigenetics | May 8, 2024 | Volume: 19 | Issue: 1 | Pages: No page available

10.1080/15592294.2024.2349980 | PMID 38716804 Get It

Full Recovery of Hearing After Resection of a Large Epidermoid Tumor at the Cerebellopontine Angle: 2-Dimensional Operative Video
Bauman, Megan M. J. , Nassiri, Ashley M. , Driscoll, Colin L. W., Link, Michael J. , Driscoll, Colin L., Bauman, Megan

Operative Neurosurgery | May 8, 2024 | Volume: 27 | Issue: 5 | Pages: 672-672

10.1227/ons.0000000000001202 | PMID 38717163 Get It

Histological analysis of laser‐enabled tissue coring with a novel 2910 nm erbium‐doped fluoride glass fiber laser
Murray, Taryn N. , Maredia, Hasina , Friedman, Paul M.

Lasers in Surgery and Medicine | May 8, 2024 | Volume: 56 | Issue: 5 | Pages: 462-465

10.1002/lsm.23792 | PMID 38716679 Get It

AbstractObjectivesThere remains an unmet need for a laser‐enabled tissue coring device that can effectively improve face and neck skin laxity and rhytides. We investigate a novel 2910 nm erbium‐doped fluoride glass fiber laser (2910 nm fiber laser) (UltraClear; Acclaro Medical) for laser‐coring of submental tissue.MethodsFive subjects, Glogau scale III−IV, were treated with a single pulse of the laser‐coring mode of the 2910 nm fiber laser in the submentum. A 4 mm punch biopsy was immediately performed. Biopsy specimens were sectioned and stained with hematoxylin and eosin and placed on glass slides. All sections were reviewed, and sections containing the center of the transected core were analyzed for depth and diameter of the ablative microchannel and width of the surrounding zone of coagulation.ResultsA total of 15 intact micro‐cores were analyzed. Histological analysis revealed an average ± standard deviation microchannel diameter of 242.5 ± 65.2 µm, an average ablative depth of 980 ± 318.8 µm, and an average zone of coagulation of 104 ± 32 µm.ConclusionsLaser‐enabled tissue coring with a novel 2910 nm fiber laser can safely achieve a wider microchannel diameter with ablative depth extending to the mid and deep dermis, which has the potential for collagen contraction and tissue tightening. Laser‐coring to this ablation diameter and depth and with the surrounding zone of coagulation was found to be safe without adverse effects of post‐inflammatory erythema or scarring in our study.